Comparative evaluation of the immunogenicity of yeast-derived (recombinant) and plasma-derived hepatitis B vaccine in infants. 1991

S K Panda, and R Ramesh, and K V Rao, and A Gupta, and A J Zuckerman, and N C Nayak
Department of Pathology, AIIMS, New Delhi.

The immunogenicity of plasma-derived (HB Vax,MSD) and recombinant hepatitis B virus (Engerix B, SK&F) vaccines was evaluated in infants born to hepatitis B virus carrier mothers. The vaccination was carried out at 1 day, 1 month, and 6 months of age using 10 micrograms of the vaccine given intramuscularly. A total of 83/88 (94.3%) and 74/79 (93.6%) of the infants receiving the plasma-derived vaccine and yeast-derived vaccine showed antibody to hepatitis B surface antigen (anti-HBs). None of the maternal factors studied apart from the HBeAg positivity corellated with vaccine failure. The yeast-derived vaccine gives marginally lower antibody titre than the plasma-derived vaccine. The group-specific anti-"a" antibody was less than 10% of the total anti-HBsAg titre. It was observed that the vaccine alone without prior administration of hepatitis B immunoglobulin is effective in perinatal infection.

UI MeSH Term Description Entries
D007194 India A country in southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. The capitol is New Delhi. Republic of India
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007232 Infant, Newborn, Diseases Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts. Neonatal Diseases,Disease, Neonatal,Diseases, Neonatal,Neonatal Disease
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection

Related Publications

S K Panda, and R Ramesh, and K V Rao, and A Gupta, and A J Zuckerman, and N C Nayak
January 1992, Vaccine,
S K Panda, and R Ramesh, and K V Rao, and A Gupta, and A J Zuckerman, and N C Nayak
January 1985, Lancet (London, England),
S K Panda, and R Ramesh, and K V Rao, and A Gupta, and A J Zuckerman, and N C Nayak
January 2000, Indian journal of pediatrics,
S K Panda, and R Ramesh, and K V Rao, and A Gupta, and A J Zuckerman, and N C Nayak
November 2002, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine],
S K Panda, and R Ramesh, and K V Rao, and A Gupta, and A J Zuckerman, and N C Nayak
July 1986, The Journal of infection,
S K Panda, and R Ramesh, and K V Rao, and A Gupta, and A J Zuckerman, and N C Nayak
April 1988, The New Zealand medical journal,
S K Panda, and R Ramesh, and K V Rao, and A Gupta, and A J Zuckerman, and N C Nayak
November 1988, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology,
S K Panda, and R Ramesh, and K V Rao, and A Gupta, and A J Zuckerman, and N C Nayak
December 1990, Hepato-gastroenterology,
S K Panda, and R Ramesh, and K V Rao, and A Gupta, and A J Zuckerman, and N C Nayak
January 1990, Acta paediatrica Scandinavica,
S K Panda, and R Ramesh, and K V Rao, and A Gupta, and A J Zuckerman, and N C Nayak
April 2001, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi,
Copied contents to your clipboard!